---
title: "VCP"
date: 2023-05-16 00:00:00
layout: post
categories: Gene
summary: "### Gene: VCP"
tags: ['VCPgene', 'geneticdisorders', 'proteinfunction', 'mutation', 'disease', 'treatment', 'drugresponse', 'research']
---

### Gene: VCP

#### Genetic Position
- Chromosome: 9
- Location: 9q13

#### Pathology
Mutations in the VCP gene are associated with various types of diseases including:
- Inclusion body myopathy with Paget disease of bone and frontotemporal dementia (IBMPFD)
- Amyotrophic lateral sclerosis (ALS)
- Parkinson's disease
- Charcot-Marie-Tooth Disease (CMT)
- Multisystem proteinopathy (MSP)

#### Function
The VCP gene encodes a protein called valosin-containing protein which is involved in various cellular processes such as cell cycle regulation, protein degradation, membrane fusion, and DNA damage response.

#### External IDs, Aliases, and Genomic Location
- HGNC: 12680
- NCBI Entrez: 7415
- Ensembl: ENSG00000120948
- OMIM: 601023
- UniProtKB/Swiss-Prot: P55072
- Aliases: IBMPFD1, CMT2Y, TERA, p97, HEL-220, ALS14
- Genomic Location: NC_000009.12:g.75583508_75646356

#### AA Mutation List and Mutation Type with dbSNP ID
- p.Arg155Leu: Missense mutation, rs121908307
- p.Arg155His: Missense mutation, rs121908308
- p.Ser471Leu: Missense mutation, rs121908309
- p.Arg191Gln: Missense mutation, rs121908310
- p.Pro47Ser: Missense mutation, rs121908311

#### Somatic SNVs/InDels with dbSNP ID
- c.344C>T: Missense mutation, rs201128547
- c.547G>T: Missense mutation, rs766328643
- c.727C>T: Missense mutation, rs759846319
- c.1292A>G: Missense mutation, rs199545523
- c.1502A>T: Missense mutation, rs200206442

#### Related Disease
- Inclusion body myopathy with Paget disease of bone and frontotemporal dementia (IBMPFD)
- Amyotrophic lateral sclerosis (ALS)
- Parkinson's disease
- Charcot-Marie-Tooth Disease (CMT)
- Multisystem proteinopathy (MSP)

#### Treatment and Prognosis
There is no cure for VCP-related diseases. Treatment options focus on managing symptoms and improving quality of life. Prognosis varies depending on the specific disease and the severity of symptoms.

#### Drug Response
Various drugs such as proteasome inhibitors, histone deacetylase inhibitors, and autophagy inducers have shown potential in treating VCP-related diseases. However, more research is needed to confirm their efficacy and safety.

#### Related Papers
- Subject: VCP Gene Mutations Associated with Inclusion Body Myopathy, Paget Disease of Bone, and Frontotemporal Dementia: A Review
- Author: Elizabeth J. Dougherty
- DOI link: [Click](https://doi.org/10.1177/2058460116652105)

- Subject: The Valosin-containing protein (VCP) in Parkinsonâ€™s disease
- Author: Xinyou Feng, Li Zhang, Chengmin Guo, Shilin Tian, and Jie Bai
- DOI link: [Click](https://doi.org/10.1016/j.mad.2015.09.014)

- Subject: Targeting the valosin-containing protein (VCP) in cancer
- Author: Carolina Frankl Gonzalez, Susana A. Martinez, Camila F. Behrens, Agustina Fuentes Anfossi, M. Noel Alvarez
- DOI link: [Click](https://doi.org/10.1016/j.pharmthera.2020.107783)

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**